» Articles » PMID: 18818201

Organic Anion Transporter OAT1 Undergoes Constitutive and Protein Kinase C-regulated Trafficking Through a Dynamin- and Clathrin-dependent Pathway

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2008 Sep 27
PMID 18818201
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Organic anion transporter 1 (OAT1) mediates the body disposition of a diverse array of environmental toxins and clinically important drugs. Therefore, understanding the regulation of this transporter has profound clinical significance. We previously demonstrate that OAT1 activity was down-regulated by activation of protein kinase C (PKC), kinetically revealed as a decrease in the maximum transport velocity V(max) without significant change in the substrate affinity K(m) of the transporter. In the current study, we showed that OAT1 constitutively internalized from and recycled back to the plasma membrane, and PKC activation accelerated OAT1 internalization without affecting OAT1 recycling. We further showed that treatment of OAT1-expressing cells with concanavalin A, depletion of K(+) from the cells, or transfection of dominant negative mutants of dynamin-2 or Eps15 into the cells, all of which block the clathrin-dependent endocytotic pathway, significantly blocked constitutive and PKC-regulated OAT1 internalization. We finally showed that OAT1 colocalized with transferrin, a marker for clathrin-dependent endocytosis, at the cell surface and in the EEA1-positive early endosomes. Together, our findings demonstrated for the first time that (i) OAT1 constitutively traffics between plasma membrane and recycling endosomes, (ii) PKC activation down-regulates OAT1 activity by altering already existent OAT1 trafficking, and (iii) OAT1 internalization occurs partly through a dynamin- and clathrin-dependent pathway.

Citing Articles

Recent Advances on the Regulations of Organic Anion Transporters.

Yu Z, You G Pharmaceutics. 2024; 16(11).

PMID: 39598479 PMC: 11597148. DOI: 10.3390/pharmaceutics16111355.


The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy.

Murray M Curr Drug Metab. 2024; 25(2):96-109.

PMID: 38441017 DOI: 10.2174/0113892002288832240213095622.


Examining the Association of Rare Allelic Variants in Urate Transporters , , and with Hyperuricemia and Gout.

Vavra J, Pavelcova K, Masinova J, Hasikova L, Bubenikova E, Urbanova A Dis Markers. 2024; 2024:5930566.

PMID: 38222853 PMC: 10787658. DOI: 10.1155/2024/5930566.


Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3.

Liang Z, You G Pharmaceutics. 2023; 15(6).

PMID: 37376173 PMC: 10303059. DOI: 10.3390/pharmaceutics15061725.


Is It Time to Use Modeling of Cellular Transporter Homeostasis to Inform Drug-Drug Interaction Studies: Theoretical Considerations.

Abbiati R, Wientjes M, Au J AAPS J. 2021; 23(5):102.

PMID: 34435271 PMC: 11048728. DOI: 10.1208/s12248-021-00635-4.


References
1.
Halpin P, Renfro J . Renal organic anion secretion: evidence for dopaminergic and adrenergic regulation. Am J Physiol. 1996; 271(5 Pt 2):R1372-9. DOI: 10.1152/ajpregu.1996.271.5.R1372. View

2.
Zhou F, Xu W, Hong M, Pan Z, Sinko P, Ma J . The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Mol Pharmacol. 2004; 67(3):868-76. DOI: 10.1124/mol.104.007583. View

3.
Williams T, Lisanti M . The caveolin proteins. Genome Biol. 2004; 5(3):214. PMC: 395759. DOI: 10.1186/gb-2004-5-3-214. View

4.
Teter K, Chandy G, Quinones B, Pereyra K, Machen T, Moore H . Cellubrevin-targeted fluorescence uncovers heterogeneity in the recycling endosomes. J Biol Chem. 1998; 273(31):19625-33. DOI: 10.1074/jbc.273.31.19625. View

5.
Vaughan R, Huff R, Uhl G, Kuhar M . Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem. 1997; 272(24):15541-6. DOI: 10.1074/jbc.272.24.15541. View